Notification from Ognian Donev in accordance with Regulation 596/2014 for receival of shares from a capital increase of Sopharma AD as of 23 July, 2025
Notification from Simeon Donev in accordance with Regulation 596/2014 for receival of shares from a capital increase of Sopharma AD as of 23 July, 2025
Notification from "Donev Investments Holding" AD in accordance with Regulation 596/2014 for receival of shares from a capital increase of Sopharma AD
Notification from "Donev Investments Holding" AD in accordance with Regulation 596/2014 for receival of shares from a capital increase of Sopharma
Notification from "Telso" AD in accordance with Regulation 596/2014 for receival of shares from a capital increase of Sopharma AD
Notification from "Sofprint Group" AD in accordance with Regulation 596/2014 for receival of shares from a capital increase of Sopharma AD
Sales revenues for June 2025
Sofia, Bulgaria, July 21, 2025 – According to the requirements of Art. 100t of the Law on Public Offering of Securities (LPOS), “Sopharma” AD (SFA: “Bulgarian Stock Exchange” AD, SPH: Warsaw Stock Exchange) notifies, that for June 2025 the Company recorded increase in sales of 49% compared to the same month of the previous year, incl. 5% increase in domestic sales and 92% increase in export sales due to the uneven recovery of sales оn the main export markets.
Notification of sale of treasury shares as of 21 July, 2025
Sofia, Bulgaria, July 21, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on July 18, 2025 the Company sold 81 170 (eighty-one thousand one hundred seventy) repurchased own shares representing 0.05% of the share capital of the Company, at a total value of BGN 203 088.00 on the Bulgarian Stock Exchange, the average price per share was BGN 2.50.
Notification of sale of treasury shares as of 18 July, 2025
Sofia, Bulgaria, July 18, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on July 17, 2025 the Company sold 72 486 (seventy two thousand four hundred eighty-six) repurchased own shares representing 0.04% of the share capital of the Company, at a total value of BGN 185 539.56 on the Bulgarian Stock Exchange, the average price per share was BGN 2.56.
Strony
- « pierwsza
- ‹ poprzednia
- …
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- …
- następna ›
- ostatnia »